Andrew Mackintosh has over 30 years of commercial and general management experience in publicly and privately owned technology businesses, during which time he has been the CEO of spin-out companies from both Oxford and Cambridge Universities.

Previously the founding chief executive of the Royal Society Enterprise Fund he is currently chairman of Sphere Fluidics Ltd, a biotechnology company aiming to transform the search for new drugs and medicines. He combines this role with a portfolio of investment and mentoring activity in support of technology companies with high growth potential.